Search results for “Globulin” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 11,909 patents, we discovered top 468 key players by total patent application. Regeneron Pharmaceuticals, Inc., Ablynx NV, F. Hoffmann-La Roche Ltd. are dominant in this area. They take 9.69% of the total patent filing.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 544
Ablynx NV
Oost-Vlaanderen, Belgium
Patent: 380
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 230
Hanmi Pharmaceutical Co., Ltd.
South Korea
Patent: 223
Behringwerke AG
Hessen, Germany
Patent: 149
Bristol Myers Squibb Co.
New York, United States
Patent: 130
Amgen, Inc.
California, United States
Patent: 130
Pfizer Inc.
New York, United States
Patent: 112
Sanofi SA
France
Patent: 106
Genentech, Inc.
California, United States
Patent: 103
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 354 patents, we discovered top 62 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, GI Innovation, Inc., Navigo Proteins GmbH are active in this area.
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 59
STARTUP
GI Innovation, Inc.
South Korea
Patent: 56
STARTUP
Navigo Proteins GmbH
Niedersachsen, Germany
Patent: 39
STARTUP
Palleon Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 19
STARTUP
Orum Therapeutics, Inc.
South Korea
Patent: 12
STARTUP
Viela Bio, Inc.
United States
Patent: 11
STARTUP
iOmx Therapeutics AG
Bayern, Germany
Patent: 11
STARTUP
Zarodex Therapeutics Ltd.
United Kingdom
Patent: 9
STARTUP
Attralus, Inc.
California, United States
Patent: 8
STARTUP
NovaGo Therapeutics AG
ZURICH, Switzerland
Patent: 8
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 5,694 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Regeneron Pharmaceuticals, Inc., Ablynx NV, Bristol Myers Squibb Co. take 8.90% of patent filing during this period.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 209
Ablynx NV
Oost-Vlaanderen, Belgium
Patent: 204
Bristol Myers Squibb Co.
New York, United States
Patent: 94
Sanofi SA
France
Patent: 91
Hanmi Pharmaceutical Co., Ltd.
South Korea
Patent: 90
Five Prime Therapeutics, Inc.
California, United States
Patent: 78
Memorial Sloan-Kettering Cancer Center
New York, United States
Patent: 74
Merck Patent GmbH
Hessen, Germany
Patent: 59
Janssen Biotech
Belgium
Patent: 59
STARTUP
GI Innovation, Inc.
South Korea
Patent: 56
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 5,694 patents in last 5 years, we discover 239 new entrants. Five Prime Therapeutics, Inc., GI Innovation, Inc., Momenta Pharmaceuticals, Inc. are the most active new entrants in this area.
Five Prime Therapeutics, Inc.
California, United States
Patent: 78
STARTUP
GI Innovation, Inc.
South Korea
Patent: 56
Momenta Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 39
Twist Bioscience Corp.
California, United States
Patent: 34
Spark Therapeutics, Inc.
Pennsylvania, United States
Patent: 31
Good T Cells Inc
United States
Patent: 28
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Beijing Shi, China
Patent: 27
LG Chem Ltd.
South Korea
Patent: 25
Onclave Therapeutics Limited
DUBLIN, Ireland
Patent: 25
Sorbonne Université
France
Patent: 23
Research Institutions
Order by:
Innovation Intensity
With the analysis among 2,542 patents, we discovered top 258 universities and scientific research institutions by total patent application. Vlaams Instituut voor Biotechnologie - Flanders Institute, The Scripps Research Institute, Baylor College of Medicine are dominant in this area. They take 8.46% of the total patent filing.
Vlaams Instituut voor Biotechnologie - Flanders Institute
Belgium
Patent: 55
The Scripps Research Institute
California, United States
Patent: 37
Baylor College of Medicine
Texas, United States
Patent: 34
University of Zurich
ZURICH, Switzerland
Patent: 31
Dartmouth College
New Hampshire, United States
Patent: 28
Ghent University
Oost-Vlaanderen, Belgium
Patent: 27
Vrije Universiteit Brussel
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 26
Sorbonne Université
France
Patent: 23
King's College London
United Kingdom
Patent: 22
President & Fellows of Harvard College
Massachusetts, United States
Patent: 22
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: